1887

Journal of General Virology header logo

Volume 81, Issue 8

Distinct patterns of alteration of genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours Free

Abstract

We previously described two genital carcinomas (IC2, IC4) containing human papillomavirus type 16 (HPV-16)- or HPV-18-related sequences integrated in chromosomal bands containing the c- (8q24) or N- (2p24) gene, respectively. The c- gene was rearranged and amplified in IC2 cells without evidence of overexpression. The N- gene was amplified and highly transcribed in IC4 cells. Here, the sequence of an 8039 bp IC4 DNA fragment containing the integrated viral sequences and the cellular junctions is reported. A 3948 bp segment of the genome of HPV-45 encompassing the upstream regulatory region and the E6 and E7 ORFs was integrated into the untranslated part of N- exon 3, upstream of the N- polyadenylation signal. Both N- and HPV-45 sequences were amplified 10- to 20-fold. The 3′ ends of the major N- transcript were mapped upstream of the 5′ junction. A minor N-/HPV-45 fusion transcript was also identified, as well as two abundant transcripts from the HPV-45 E6–E7 region. Large amounts of N-myc protein were detected in IC4 cells. A major alteration of c- sequences in IC2 cells involved the insertion of a non-coding sequence into the second intron and their co-amplification with the third exon, without any evidence for the integration of HPV-16 sequences within or close to the gene. Different patterns of gene alterations may thus be associated with integration of HPV DNA in genital tumours, including the activation of the protooncogene via a mechanism of insertional mutagenesis and/or gene amplification.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-8-1983
2000-08-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/8/0811983a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-8-1983&mimeType=html&fmt=ahah

References

  1. Biedler J. L., Spengler B. A. 1976; Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science 191:185–187
     [Google Scholar]
  2. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Shiffman M. H., Moreno V., Kurman R., Shah K. V. 1995; Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute 87:796–802
     [Google Scholar]
  3. Bourhis J., Lê M., Barrois M., Gerbaulet A., Jeannel D., Duvillard P., Le Doussal V., Chassagne D., Riou G. 1990; Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. Journal of Clinical Oncology 8:1789–1796
     [Google Scholar]
  4. Brodeur G. M., Seeger R. C., Schwab M., Varmus H. E., Bishop J. M. 1984; Amplification of N- myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121–1124
     [Google Scholar]
  5. Cannizzaro L. A., Dürst M., Mendez M. J., Hecht B. K., Hecht F. 1988; Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genetics and Cytogenetics 33:93–98
     [Google Scholar]
  6. Choo K. B., Huang C. J., Chen C. M., Han C. P., Au L. C. 1995; Jun -B oncogene aberrations in cervical cancer cell lines. Cancer Letters 93:249–253
     [Google Scholar]
  7. Coombs L. M., Pigott D., Proctor A., Eydmann M., Denner J., Knowles M. A. 1990; Simultaneous isolation of DNA, RNA, and antigenic protein exhibiting kinase activity from small tumor samples using guanidine isothiocyanate. Analytical Biochemistry 188:338–343
     [Google Scholar]
  8. Couturier J., Sastre-Garau X., Schneider-Maunoury S., Labib A., Orth G. 1991; Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. Journal of Virology 65:4534–4538
     [Google Scholar]
  9. Cullen A. P., Reid R., Campion M., Lörincz A. T. 1991; Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. Journal of Virology 65:606–612
     [Google Scholar]
  10. Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S. 1997; The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. Journal of General Virology 78:1095–1101
     [Google Scholar]
  11. de Crémoux P., Thioux M., Peter M., Vielh P., Michon J., Delattre O., Magdelénat H. 1997; Polymerase chain reaction compared with dot blotting for the determination of N-myc gene amplification in neuroblastoma. International Journal of Cancer 72:518–521
     [Google Scholar]
  12. Dürst M., Kleinheinz A., Hotz M., Gissmann L. 1985; The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Journal of General Virology 66:1515–1522
     [Google Scholar]
  13. Dürst M., Croce C. M., Gissmann L., Schwarz E., Huebner K. 1987; Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proceedings of the National Academy of Sciences USA: 84:1070–1074
     [Google Scholar]
  14. Fourel G., Trepo C., Bougueleret L., Henglein B., Ponzetto A., Tiollais P., Buendia M. A. 1990; Frequent activation of N- myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 347:294–298
     [Google Scholar]
  15. Frohman M. A., Dush M. K., Martin G. R. 1988; Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proceedings of the National Academy of Sciences, USA 85:8998–9002
     [Google Scholar]
  16. Gallego M. I., Zimonjic D. B., Popescu N. C., DiPaolo J. A., Lazo P. A. 1994; Integration site of human papillomavirus type-18 DNA in chromosome band 8q22.1 of C4-1 cervical carcinoma: DNAse-I hypersensitivity and methylation of cellular flanking sequences. Genes Chromosomes & Cancer 9:28–32
     [Google Scholar]
  17. Gazin C., Dupont de Dinechin S., Hampe A., Masson J. M., Martin P., Stehelin D., Galibert F. 1984; Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO Journal 3:383–387
     [Google Scholar]
  18. Geisbill J., Osmers U., Dürst M. 1997; Detection and characterization of human papillomavirus type 45 DNA in cervical carcinoma cell line MS751. Journal of General Virology 78:655–658
     [Google Scholar]
  19. Hori T. A., Ichimura H., Minamihisamatsu M., Takahashi E. I., Yamauchi M., Hama Y., Kurimura O., Yamasaki M., Kurimura T. 1991; Chromosomal insertion and amplification of human papillomavirus 16 DNA sequences in a cell line of Argyrophil small cell carcinoma of the uterine cervix. Japanese Journal of Cancer Research 82:371–375
     [Google Scholar]
  20. Jeon S., Lambert P. F. 1995; Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proceedings of the National Academy of Sciences, USA 92:1654–1658
     [Google Scholar]
  21. Jones T. R., Cole M. D. 1987; Rapid cytoplasmic turnover of c- myc mRNA: requirement of the 3′ untranslated sequences. Molecular and Cellular Biology 7:4513–4521
     [Google Scholar]
  22. Koopman L. A., Szuhai K., van Eendenburg J. D. H., Bezrookove V., Kenter G. G., Schuuring E., Tanke H., Fleuren G. J. 1999; Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer Research 59:5615–5624
     [Google Scholar]
  23. Lazo P. A., DiPaolo J. A., Popescu N. C. 1989; Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5′-flanking cellular sequence located near the myc protooncogene in HeLa cells. Cancer Research 49:4305–4310
     [Google Scholar]
  24. Lazo P. A., Gallego M. J., Ballester S., Feduchi E. 1992; Genetic alterations by human papillomaviruses in oncogenesis. FEBS Letters 300:109–113
     [Google Scholar]
  25. Lee W. H., Murphree A. L., Benedict W. F. 1984; Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309:458–460
     [Google Scholar]
  26. Lüscher B., Larsson L.-G. 1999; The basic region/helix–loop–helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene 18:2955–2966
     [Google Scholar]
  27. Macville M., Schröck E., Padilla-Nash H., Keck C., Ghadimi B. M., Zimonjic D., Popescu N., Ried T. 1999; Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Research 59:141–150
     [Google Scholar]
  28. Magrath I. 1990; The pathogenesis of Burkitt’s lymphoma. Advances in Cancer Research 55:133–270
     [Google Scholar]
  29. Mäkelä T. P., Saksela K., Alitalo K. 1989; Two N- myc polypeptides with distinct amino termini encoded by the second and third exons of the gene. Molecular and Cellular Biology 9:1545–1552
     [Google Scholar]
  30. Manos M. M., Ting Y., Wright D. K., Lewis A. J., Broker T. R., Wolinsky S. R. 1989; The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209–214
     [Google Scholar]
  31. Mincheva A., Gissmann L., zur Hausen H. 1987; Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Medical Microbiology and Immunology 176:245–256
     [Google Scholar]
  32. Myers G., Delius H., Icenogle J., Bernard H.-U., Favre M., Van Ranst M. 1994 Human Papillomaviruses 1994. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences Los Alamos, NM: Los Alamos National Laboratory;
  33. Naghashfar Z. S., Rosenshein N. B., Lorincz A. T., Buscema J., Shah K. V. 1987; Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. Journal of General Virology 68:3073–3079
     [Google Scholar]
  34. Nau M. M., Brooks B. J., Carney D. N., Gazdar A. F., Battey J. F., Sausville E. A., Minna J. D. 1986; Human small-cell lung cancers show amplification and expression of the N- myc gene. Proceedings of the National Academy of Sciences, USA 83:1092–1096
     [Google Scholar]
  35. Nesbit C. E., Tersak J. M., Prochownik E. V. 1999; MYC oncogenes and human neoplastic disease. Oncogene 18:3004–3016
     [Google Scholar]
  36. Ocadiz R., Sauceda R., Cruz M., Graef A. M., Gariglio P. 1987; High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Research 47:4173–4177
     [Google Scholar]
  37. Popescu N. C., Zimonjic D., DiPaolo J. A. 1990; Viral integration, fragile sites, and proto-oncogenes in human neoplasia. Human Genetics 84:383–386
     [Google Scholar]
  38. Reuter S., Bartelmann M., Vogt M., Geisen C., Napierski I., Kahn T., Delius H., Lichter P., Weitz S., Korn B., Schwarz E. 1998; APM - 1 , a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO Journal 17:215–222
     [Google Scholar]
  39. Riou G., Barrois M., Dutronquay V., Orth G. 1985 Presence of papillomavirus DNA sequences, amplification of c - myc and c-Ha- ras oncogenes and enhanced expression of c - myc in carcinomas of the uterine cervix Papillomaviruses, Molecular and Clinical Aspects 47–56 New York: Alan R. Liss;
     [Google Scholar]
  40. Romanczuk H., Howley P. M. 1992; Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proceedings of the National Academy of Sciences, USA 89:3159–3163
     [Google Scholar]
  41. Sambrook J., Fritsch E., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual , 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
  42. Sastre-Garau X., Couturier J., Favre M., Orth G. 1995; A recurrent human papillomavirus integration site at chromosome region 12q14–q15 in SW756 and SK-v cell lines derived from genital tumors. Comptes Rendus de l’Académie des Sciences Série III 318:475–478
     [Google Scholar]
  43. Schneider-Maunoury S., Croissant O., Orth G. 1987; Integration of human papillomavirus type16 DNA sequences: a possible early event in the progression of genital tumors. Journal of Virology 61:3295–3298
     [Google Scholar]
  44. Schwab M., Ellison J., Busch M., Rosenau W., Varmus H. E., Bishop J. M. 1984; Enhanced expression of the human gene N- myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proceedings of the National Academy of Sciences, USA 81:4940–4944
     [Google Scholar]
  45. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111–114
     [Google Scholar]
  46. Shah K., Howley P. M. 1996; Papillomaviruses. In Fields Virology pp 2077–2109 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  47. Stanton L. W., Schwab M., Bishop J. M. 1986; Nucleotide sequence of the N- myc gene. Proceedings of the National Academy of Sciences, USA 83:1772–1776
     [Google Scholar]
  48. Stewart A. C. M., Eriksson A. M., Manos M. M., Muñoz N., Bosch F. X., Peto J., Wheeler C. M. 1996; Intratype variation in 12 human papillomavirus types: a worldwide perspective. Journal of Virology 70:3127–3136
     [Google Scholar]
  49. Thierry F. 1993; Proteins involved in the control of HPV transcription. Papillomavirus Reports 4:27–32
     [Google Scholar]
  50. Transy C., Fourel G., Robinson W. S., Tiollais P., Marion P. L., Buendia M. A. 1992; Frequent amplification of c- myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proceedings of the National Academy of Sciences, USA 89:3874–3878
     [Google Scholar]
  51. van Lohuizen M., Breuer M., Berns A. 1989; N- myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. EMBO Journal 8:133–136
     [Google Scholar]
  52. Wei Y., Fourel G., Ponzetto A., Silvestro M., Tiollais P., Buendia M. A. 1992; Hepadnavirus integration: mechanisms of activation of the N- myc 2 retrotransposon in woodchuck liver tumors. Journal of Virology 66:5268–5276
     [Google Scholar]
  53. Wenzel A., Cziepluch C., Hamann U., Schürmann J., Schwab M. 1991; The N-myc oncoprotein is associated in vivo with the phosphoprotein Max (p20/22) in human neuroblastoma cells. EMBO Journal 10:3703–3712
     [Google Scholar]
  54. Wilke C. M., Hall B. K., Hoge A., Paradee W., Smith D. I., Glover T. W. 1996; FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Human Molecular Genetics 5:187–195
     [Google Scholar]
  55. zur Hausen H. 1996; Papillomavirus infections: a major cause of human cancers. Biochimica et Biophysica Acta 1288:F55–F78
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-8-1983
Loading
Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours
J. Gen. Virol. 81, 1983 (2000); https://doi.org/10.1099/0022-1317-81-8-1983
/content/journal/jgv/10.1099/0022-1317-81-8-1983
/content/journal/jgv/10.1099/0022-1317-81-8-1983
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error